Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.37M | 8.21M | 42.47M | 10.79M | 9.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.37M | 8.21M | 42.47M | 10.79M | 9.63M |
| Cost of Revenue | 14.92M | 14.90M | 17.25M | 16.59M | 16.13M |
| Gross Profit | -1.54M | -6.69M | 25.22M | -5.80M | -6.50M |
| SG&A Expenses | 4.80M | 4.68M | 5.42M | 5.09M | 4.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.72M | 19.58M | 22.67M | 21.67M | 20.72M |
| Operating Income | -6.34M | -11.37M | 19.80M | -10.88M | -11.09M |
| Income Before Tax | -3.86M | -9.08M | 22.09M | -9.20M | -10.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.86M | -9.08M | 22.09M | -9.20M | -10.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.86M | -9.08M | 22.09M | -9.20M | -10.20M |
| EBIT | -6.34M | -11.37M | 19.80M | -10.88M | -11.09M |
| EBITDA | -6.32M | -11.34M | 19.83M | -10.85M | -11.06M |
| EPS Basic | -0.20 | -0.54 | 1.30 | -0.72 | -1.33 |
| Normalized Basic EPS | -0.13 | -0.34 | 0.82 | -0.45 | -0.83 |
| EPS Diluted | -0.20 | -0.54 | 1.30 | -0.72 | -1.33 |
| Normalized Diluted EPS | -0.13 | -0.34 | 0.82 | -0.45 | -0.83 |
| Average Basic Shares Outstanding | 18.85M | 16.90M | 16.94M | 12.69M | 7.66M |
| Average Diluted Shares Outstanding | 18.85M | 16.90M | 16.94M | 12.69M | 7.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |